FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Herz-Jesu-Krankenhaus Hiltrup
Hospital
Location:
Münster-Hiltrup, Germany (DE)
ISNI
: 000000405573780
Publications
(9)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Improved Persistence to Medication, Decreased Cardiovascular Events and Reduced All-Cause Mortality in Hypertensive Patients with Use of Single-Pill Combinations: Results from the START-Study (2023)
Schmieder R, Wassmann S, Predel HG, Weisser B, Blettenberg J, Gillessen A, Randerath O, et al.
Journal article
Single pill treatment in daily practice is associated with improved clinical outcomes and all-cause mortality in cardiovascular diseases: results from the START project (2022)
Weisser B, Wilke T, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, et al.
Conference contribution
Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany (2022)
Wilke T, Weisser B, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, et al.
Journal article
Effects of Single Pill Combinations Compared to Identical Multi Pill Therapy on Outcomes in Hypertension, Dyslipidemia and Secondary Cardiovascular Prevention: The START-Study (2022)
Wilke T, Weisser B, Predel HG, Schmieder R, Wassmann S, Gillessen A, Blettenberg J, et al.
Journal article
THE SINGLE PILL CONCEPT LEADS TO IMPROVED PERSISTENCE OF MEDICATION, CLINICAL OUTCOMES AND REDUCED ALL-CAUSE MORTALITY IN HYPERTENSIVE PATIENTS - RESULTS FROM THE START PROJECT (2021)
Predel HG, Weisser B, Wassmann S, Gillessen A, Blettenberg J, Fournier V, Noetel A, et al.
Conference contribution
Persistence and cardiovascular outcomes with ramipril, atorvastatin, ASA as a single pill compared to the multi pill combination. A subanalysis of the START study, a claims data analysis (2020)
Predel HG, Weisser B, Wassmann S, Schmieder R, Blettenberg J, Gillessen A, Fournier , et al.
Conference contribution
Single pill regimen improves persistence and leads lo better clinical outcome compared to identical multi pill combination. Results of START, a German claims data analysis (2020)
Predel HG, Weisser B, Schmieder R, Wassmann S, Blettenberg J, Gillessen A, Fournier , et al.
Conference contribution
Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany—Updated series of 120 cases (2020)
Kermer P, Eschenfelder CC, Diener HC, Grond M, Abdalla Y, Abraham A, Althaus K, et al.
Journal article
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation (2019)
Pfeuffer S, Schmidt R, Straeten FA, Pul R, Kleinschnitz C, Wieshuber M, Lee DH, et al.
Journal article